BioNTech SE (BNTX)
105.76
-3.62
(-3.31%)
USD |
NASDAQ |
Feb 12, 16:00
107.53
+1.77
(+1.67%)
Pre-Market: 09:28
BioNTech Cash from Investing (Quarterly) : -994.84M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CureVac NV | -0.447M |
| Novavax, Inc. | -136.53M |
| Pfizer Inc. | -- |
| Sanofi | -- |
| Moderna, Inc. | 700.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 854.07M |
| Cash from Financing (Quarterly) | -14.05M |
| Free Cash Flow | -588.89M |
| Free Cash Flow Per Share (Quarterly) | 3.262 |
| Free Cash Flow to Equity (Quarterly) | 812.49M |
| Free Cash Flow to Firm (Quarterly) | 783.82M |
| Free Cash Flow Yield | -2.32% |